AJICAP Second Generation: Improved Chemical Site-Specific Conjugation Technology for Antibody–Drug Conjugate ProductionTomohiro Fujii, Kei Yamada, Sayaka Kawaguchi et al.|Bioconjugate Chemistry|2023Cited by 62
Chemical Site-Specific Conjugation Platform to Improve the Pharmacokinetics and Therapeutic Index of Antibody–Drug ConjugatesYutaka Matsuda, Tatsuya Okuzumi, Takuya Seki et al.|Molecular Pharmaceutics|2021Cited by 61
AJICAP Second Generation: Improved Chemical Site-Specific Conjugation Technology for Antibody-Drug Conjugate ProductionTomohiro Fujii, Kei Yamada, Yutaka Matsuda et al.|ChemRxiv|2023Cited by 20
Biological Evaluation of Maytansinoid-Based Site-Specific Antibody-Drug Conjugate Produced by Fully Chemical Conjugation Approach: AJICAP®Takuya Seki, Tatsuya Okuzumi, Kei Yamada et al.|Frontiers in Bioscience-Landmark|2022Cited by 8